<i>FGFR</i> Alterations in Thyroid Carcinoma: A Novel Class of Primary Drivers with Significant Therapeutic Implications and Secondary Molecular Events Potentially Mediating Resistance in Thyroid Malignancy-Reference-Cited by-同舟云学术

FGFR Alterations in Thyroid Carcinoma: A Novel Class of Primary Drivers with Significant Therapeutic Implications and Secondary Molecular Events Potentially Mediating Resistance in Thyroid Malignancy

Published:2024-09-09 Issue: Volume: Page:
ISSN:2329-9738
Container-title:VideoEndocrinology™
language:en
Short-container-title:VideoEndocrinology™

Author:

Sabbagh Mark F.¹,Janovitz Tyler²,Dias-Santagata Dora¹,Siegmund Stephanie³,Nardi Valentina¹,Wirth Lori J.⁴,Randolph Gregory W.⁵,Lennerz Jochen K.⁶,Decker Brennan²,Nose Vania¹,Alzumaili Bayan A.¹,Faquin William C.¹,Barletta Justine A.³,Le Long P.¹,Iafrate A. John¹,Sadow Peter M.¹,Fisch Adam S.¹^ORCID

Affiliation:

1. Departments of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

2. Foundation Medicine, Inc., Cambridge, Massachusetts, USA.

3. Departments of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA.

4. Departments of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

5. Departments of Otolaryngology – Head and Neck Surgery, Massachusetts Eye and Ear and Harvard Medical School, Boston, Massachusetts, USA.

6. BostonGene Corporation, Waltham, Massachusetts, USA.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/ve.2024.0016

Reference12 articles.

1. Thyroid Cancer Incidence and Mortality Trends in the United States: 2000–2018

2. Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors

3. Integrated Genomic Characterization of Papillary Thyroid Carcinoma

4. Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases

5. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers